Previous studies have indicated that denervation of adult rodent sweat glands results in the loss of secretory responsiveness to muscarinic agonists. To elucidate the molecular basis of this loss, we have characterized the muscarinic cholinergic receptor present in adult rat sweat glands and examined the effects of cholinergic denervation on its properties and expression. When homogenates of gland-rich tissue from adult animals were assayed with [KmethyL3H]-scopolamine, a high-affinity muscarinic antagonist, the concentration of muscarinic receptors was 301 fmollmg protein and the affinity was 13 1 pm. Autoradiographic analysis demonstrated that ligand binding sites were detectable only on glands. In competition studies with well-characterized muscarinic agents, the receptor exhibited typical muscarinic pharmacology. Further investigation with the selective muscarinic antagonists 4-diphenylacetoxy-Kmethylpiperidine methiodide, pirenzepine, and AF DX-116 revealed that the sweat gland receptor belongs to the M, glandular pharmacological subtype. In situ hybridization histochemistry with receptor subtype-specific oligonucleotide probes indicated that rat sweat glands express the m3 molecular receptor subtype. Seven days after sciatic nerve transection, when denervated glands were compared to those on the contralateral unoperated side, there was no significant difference either in the concentration or affinity of muscarinic binding sites or in receptor density or distribution. Furthermore, the molecular subtype and the level of its expression were unchanged. Thus, it appears that muscarinic binding sites and m3 receptor mRNA are present in denervated sweat glands that are unresponsive to muscarinic stimulation. These results suggest that the regulation of responsiveness occurs at a point distal to the expression of muscarinic receptors.
Previous studies have indicated that denervation of adult rodent sweat glands results in the loss of secretory responsiveness to muscarinic agonists. To elucidate the molecular basis of this loss, we have characterized the muscarinic cholinergic receptor present in adult rat sweat glands and examined the effects of cholinergic denervation on its properties and expression. When homogenates of gland-rich tissue from adult animals were assayed with [KmethyL3H]-scopolamine, a high-affinity muscarinic antagonist, the concentration of muscarinic receptors was 301 fmollmg protein and the affinity was 13 1 pm. Autoradiographic analysis demonstrated that ligand binding sites were detectable only on glands. In competition studies with well-characterized muscarinic agents, the receptor exhibited typical muscarinic pharmacology. Further investigation with the selective muscarinic antagonists 4-diphenylacetoxy-Kmethylpiperidine methiodide, pirenzepine, and AF DX-116 revealed that the sweat gland receptor belongs to the M, glandular pharmacological subtype. In situ hybridization histochemistry with receptor subtype-specific oligonucleotide probes indicated that rat sweat glands express the m3 molecular receptor subtype. Seven days after sciatic nerve transection, when denervated glands were compared to those on the contralateral unoperated side, there was no significant difference either in the concentration or affinity of muscarinic binding sites or in receptor density or distribution. Furthermore, the molecular subtype and the level of its expression were unchanged. Thus, it appears that muscarinic binding sites and m3 receptor mRNA are present in denervated sweat glands that are unresponsive to muscarinic stimulation. These results suggest that the regulation of responsiveness occurs at a point distal to the expression of muscarinic receptors.
Muscarinic cholinergic receptors are a family of closely related molecular subtypes that possess distinct functional properties (reviewed by Nathanson, 1987; Bonner, 1989; Hulme et al., 1990) . The heterogeneity of this receptor class was initially revealed in pharmacological studies. Based on differing affinities for the antagonist pirenzepine in competition experiments with [N-methyl-3H]-scopolamine (t3H]NMS), muscarinic receptors were divided into three broad pharmacological classes (designated by "M"): a high-affinity or M, site found predominantly in brain (K, < 10 nM) and intermediate-and low-affinity sites located predominantly in peripheral autonomic targets (K;s = 300 and 800-1000 nM, respectively), which have been collectively designated as M, (Hammer et al., 1980) . Parotid and lacrimal glands possess the intermediate-affinity site, while heart contains the low-affinity site (Hammer et al., 1980) . The characterization of these classes was further refined following the development of two additional compounds; 4diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) possesses high affinity for most exocrine gland receptors and AF DX-116 possesses high affinity for the heart receptor (Barlow and Shepherd, 1986; Hammer et al., 1986) . Based on these studies, the M, receptors have been subclassified as M, cardiac and M, glandular (Barlow and Shepherd, 1986; Hammer et al., 1986) .
Subsequent molecular cloning studies have demonstrated that in both humans and rats muscarinic receptors comprise a family of five related genes (designated by "m"), ml-m5 (Kubo et al., 1986a,b; Bonner et al., 1987 Bonner et al., , 1988 Peralta et al., 1987a,b) . The mRNAs that correspond to these proteins have a heterogeneous distribution in peripheral autonomic targets and CNS (Peralta et al., 1987a; Buckley et al., 1988; Maeda et al., 1988) . For each molecular subtype, competition studies performed with cell lines transfected with cDNAs encoding a single molecular subtype have yielded distinct pharmacological profiles (Peralta et al., 1987a; Akiba et al., 1988; Bonner et al., 1988; Buckley et al., 1989) ; for example, the ml receptor possesses high affinity for pirenzepine and low affinity for AF DX-116, while the m2 receptor exhibits high affinity for AF DX-116 and low affinity for pirenzepine and 4-DAMP. These two molecular subtypes, ml and m2, are believed to correspond to the M, and M, heart pharmacological subtypes. Analysis of cell expression systems has also suggested that particular molecular subtypes are preferentially coupled to specific intracellular effecters. The m 1, m3, and m5 subtypes interact with phospholipase C and thus activate the phosphoinositide (PI) pathway, whereas the m2 and m4 receptors are coupled to inhibition of adenyl cyclase (Ashkenaziet al., 1987; Fukudaet al., 1988; Joneset al., 1988; Peralta et al., 1988) . Although the diversity of this receptor family is now well established, relatively little is known about the specific distributions of the different molecular subtypes in peripheral tissues and the relationship between particular molecular subtypes and pharmacological properties in vivo. Choline@ denervation of peripheral targets produces diverse effects on muscarinic receptor expression. Denervation of cat iris by extirpation of the ciliary ganglion produces no change in the concentration or affinity of muscarinic receptors (Sachs et al., 1979) . In contrast, parasympathectomy of rat urinary bladder produces an increase in the concentration of muscarinic receptors; a portion of this increase, however, may result from the compensatory hypertrophy that accompanies bladder denervation (Nilvebrant et al., 1986) . Finally, denervation of rat parotid gland produces a decrease in the number of muscarinic receptors (Talamo et al., 1979) . Since muscarinic receptors are heterogeneous and the several subtypes may be regulated differently, the varying responses to denervation could reflect differences in the molecular subtype expressed by target cells. In none of the studies to date, however, has the expression of specific molecular subtypes been examined. Therefore, it remains unclear whether the observed changes in the level of receptor expression, or lack thereof, are related to the specific target cell types or, alternatively, whether they are a function of the molecular subtype(s) expressed.
Rat eccrine sweat glands provide an interesting model system to study the expression and regulation of muscarinic receptors. In rats, sweat glands are concentrated in footpads. The innervation of rat sweat glands is sympathetic in origin but cholinergic in pharmacology; sweat secretion can be elicited by cholinergic agonists, and muscarinic cholinergic antagonists block nerveevoked sweat secretion (Stevens and Landis, 1987) . ChAT and AChE, the enzymes of synthesis and degradation of ACh, are present in the gland innervation (Landis and Keefe, 1983; Leblanc and Landis, 1986) . Previous studies have raised the possibility that muscarinic ACh receptors are downregulated following denervation. Sweat secretion in response to cholinergic agonists disappears after denervation in the rat (Hayashi and Nakagawa, 1963) . Similarly, denervation of mouse sweat glands yields glands that are unresponsive to cholinergic agonists; interestingly, the glands regain responsiveness following collateral reinnervation . Thus, secretory responsiveness of rat and mouse sweat glands depends upon functional innervation. The effects of denervation on rodent sweat gland responsiveness differ from those of denervation on responsiveness of other autonomic targets. In parotid gland (Talamo et al., 1979; Ekstrom, 1980) , iris (Sachs et al., 1979) , and urinary bladder (Nilvebrant et al., 1986) , denervation results in supersensitivity to cholinergic agonists.
To learn more about the role of innervation in the regulation of neurotransmitter receptors and responsiveness in autonomic tissues, we have examined the expression and properties of muscarinic receptors in rat sweat glands. Our studies demonstrate that sweat gland receptors display the characteristics of the muscarinic receptor defined pharmacologically as the M, glandular subtype and they correspond to the m3 molecular subtype. We have investigated the expression of muscarinic receptors in denervated rat sweat glands and found that, although sweat secretion is absent, receptor properties and number are unchanged. Our results suggest that functional sympathetic cholinergic innervation plays a central role in the maintenance of secretory function at a site distinct from the receptor. Preliminary reports of these studies have appeared previously Landis, 1988, 1989 Animals. Litters and adult Sprague-Dawley rats were obtained from Zivic-Miller (Zelienople, PA). The sweat glands of adult rats were denervated by cutting the sciatic nerve. Rats were deeply anesthetized with chloral hydrate, the lateral aspect of the upper thigh was shaved, and the surgical area was swabbed with ethanol. A 2-3 cm longitudinal incision was made over the head of the humerus. The sciatic nerve was visualized by reflecting the inferior aspect of the gluteus maximus superiorly and reaching under the biceps femoris. A 1.5 cm segment of sciatic nerve was removed, and the wound was closed with wound clips.
Secretion assay. Sweat secretion was assayed by making a silicone elastic (Kerr Co., Romulus, MI) mold of the plantar surface of the rat footpad as described previously Stevens and Landis, 1987) . Animals were injected subcutaneously with 3 mg&g of pilocarpine, and the impression material was applied 20 min later and allowed to harden. The impression material is not miscible with water; therefore, each sweat droplet forms a small pore in the mold as the material hardens. Since each pore represents the response of an individual sweat gland, the secretory response may be quantitated with a dissecting microscope.
Muscarinic receptor assay. Gland-rich tissue was collected for assay by removing footpads and carefully dissecting away the dermis and epidermis; this procedure yielded small chunks of tissue containing sweat glands, connective tissue, and fat cells. The tissue was frozen on dry ice and stored at -70°C. At the time of assay, the tissue chunks were suspended in ice-cold homogenization buffer containing 10 mM phosphate buffer (pH 7.2), 125 mM NaCl, 2 mM KCl, 5 mM MgCl,, and 1 mM EDTA and homogenized with a Potter-Elvejhem glass-Teflon homogenizer. The suspension was filtered through a single layer of cheesecloth and then homogenized further with a Brinkmann Polytron. The crude homogenate was centrifuged at 50,000 x g for 15 min, the supematant was discarded, and the crude membrane pellet was resuspended in homogenization buffer. This procedure was repeated twice, and the final pellet was resuspended in homogenization buffer at a protein concentration of approximately 0.2-0.4 mg/ml.
The concentration and alTmity of muscarinic ligand binding sites were determined using the nonselective muscarinic receptor antagonist [W methyl-3H]-scopolamine ([)H]NMS). Binding assays were performed at room temperature by incubating 100 pl of &de membranes (20-40 pg per assay tube) with 900 ~1 of assay buffer (20 mM HEPES. 125 mM !VaCl, 5 mu M&l,, 1 mM EGTA, a& 1 mM tiTT) containing'[3H]NMS (0.025-l .2 no) for 50 min. Preliminary studies indicated that the specific binding was maximal after 30 min and linear over a protein concentration range of 20-400 &ml (data not shown). The binding assay was terminated by the addition of 5 ml of ice-cold assay buffer. The samples were rapidly filtered over #32 glass fiber filters (Schleicher & Schuell, Keene, NH) and washed twice with 5 ml of ice-cold assay buffer using a Brandel cell harvester (model M-24R, Brandel, Inc., Gaithersburg, MD). Filters were transferred to scintillation vials and counted. Specific binding was defined as the number of total counts bound minus the nonspecific counts bound in the presence of 10 PM atropine sulfate. Binding data were analyzed by the method of Scatchard (1949) analysis, the Kd of the receptor was determined to be 13 1 + 6 PM, and the B,,,, 301 f 23 fmol/mg protein (n = 5).
Receptor autoradiography.
Light microscopic autoradiography was performed essentially as previously described (Wamsley et al., 1981; Herkenham, 1985) . In brief, rats were perfused through the left ventricle with ice-cold phosphate-buffered saline (PBS; pH 7.2). The rear footpads were rapidly removed, mounted in OCT compound (Miles Labs Inc.), and frozen. Ten-micron sections were thaw-mounted onto untreated glass slides and stored at -20°C. Prior to labeling, the tissue sections were warmed to room temperature. Sections were incubated with 1 11~ [3H]NMS in PBS for 50 min at room temperature, dipped in distilled water to terminate the incubation. washed twice in ice-cold PBS for 2.5 mitt, and finally dipped in distilled water. Nonspecific binding was assayed by processing sections under identical conditions in the presence of 10 PM atropine sulfate. The tissue sections were dried and stored overnight at 4°C prior to application of emulsion-coated coverslips. The coverslips (No. 1, 25 x 77 mm; Diamond Brand, Gaitbersburg, MD) were coated with a uniform laver of NTB-3 DhotoEraDhic emulsion diluted 1: 1 with water, glued to the frosted end-of th; slide with Super Glue, and clamped in place. After exposures of 3-l 3 weeks at 4°C in a desiccated chamber, the autoradiograms were developed in D-19 at 17°C for 2.5 mm, washed for 15 set in distilled water, and hxed for 5 min. The tissue sections were stained with 0.4% cresyl violet in water, dried overnight, and mounted with DPX (BDH Limited, Poole, UK). Secretory coils were outlined for analysis by examination of the cresyl violetstained section. Grains per area were determined over glands from control and denervated animals using an Olympus Cue-4 image analysis system. Specific grain densities were calculated by subtracting the value of nonspecific grain density found in the presence of 10 PM atropine from the total grain density. Autoradiographic exposure times were the same for the control and denervated sweat gland sections. Specific grain counts from different groups were compared for statistical significance using the Student's t test.
In situ hybridization histochemistry.
Frozen sections of rat footpad were cut. thaw-mounted onto gelatin-coated slides, and stored at -80°C. Prior tohybridization, tissue-&ctions were warn& for 5 min at room temperature and then hxed for 5 min in 4% paraformaldehyde in 0.1 M ohosnhate buffer. The slides were then rinsed in PBS and processed ashes&bed previously with minor modifications (Young et al., 1986; Siegel, 1988) . Slides were immersed in 0.25% acetic anhydride in 0.1 M triethanolamine (PH 8.0) for 10 min. The sections were rinsed in 2 x SSC (1 x SSC = 0.15 M NaCI, 0.015 M sodium citrate, pH 7.0) and dehydrated through graded alcohols. The sections were then immersed in chloroform for 10 min followed by a second 10 min incubation in 95% ethanol and air dried. The sections were prehybridized with 50 ~1 of hybridization buffer (4 x SSC, 50% formamide, 10% dextran sulfate, 2 m&ml bovine serum albumin, 1 mg/ml yeast tRNA, and 1 mg/ml ssDNA) for 5 hr at room temperature.
Sections were covered with Parafilm coverslips to prevent drying. Following prehybtidization, the sections were incubated with 50 ~1 of hybridization buffer containing 7.5 x 1 OS cpm of 35S-labeled probe and 100 mM DTT for 22 hr at room temperature. After incubation, the Parafilm coverslips were floated off in 2 x SSC, and the sections were washed four times for 15 mm in 50% a, Bright-field view of the secretory coil of an adult rat sweat gland. b, In the same field as a viewed in dark-field, grains are concentrated over the secretory coil. c and d, Bright-and dark-field views of the secretory coil following binding in the presence of 10 PM atropine. Only background levels of grains were observed. e, Bright-field view of an arteriole in the footpad. J; When the same field as e is examined with dark-field optics, ligand binding sites are not detectable. Autoradiograms were exposed for 12 weeks. Magnification, 3 15 x .
formamide/ x SSC at 42°C and two times for 60 min each in 1 x SSC at room temperature. Following these washes, the sections were dried overnight at room temperature. The slides were dipped in emulsion diluted 1: 1 with water and exposed at 4°C in a desiccated chamber for 6-8 weeks. The autoradiographs were developed in D19, stained, and mounted as described above. Grain density was determined by counting the number of grains over the area of a sweat gland as described above for receptor autoradiography.
The background or nonspecific grain density was determined by two methods. First, the grain density over glands hybridized with the m2 probe was determined; message for the m2 receptor in the periphery has only been found in the heart and thus should not be present in sections of footpad. Second, the density of grains in sections hybridized with the m3 probe was determined over areas that contained connective tissue and fat cells but not sweat glands. The background grain density determined by these methods was similar, and specific counts were determined by subtracting the background density from the total. Specific grain counts from different groups were compared for statistical significance using the Student's t test.
Probes. Oligodeoxynucleotide probes were made by solid-phase synthesis on an Applied Biosystem DNA synthesizer (courtesy of Dr. Bruce Levison, Case Western Reserve University, School ofMedicine). Probes 45 (m4) or 48 (m1,2,3,5) bases in length were made complementary to the region of the mRNA encoding the N-terminal domains of the receptor sequences. Most of these probes (m 1,3,4,5) are identical to those previously characterized by others using Northern blot analysis (Banner et al., 1987; Buckley et al., 1988) . The m2 probe was complementary to bases 4-51 of the sequence reported by Gocayne et al. (1987) . All probes were characterized on sections of other autonomic targets as well as on sections of rat brain (M. P. Grant and S. C. Landis, unpublished observations) and yield distributions similar to those reported previously (Peralta et al., 1987a; Buckley et al., 1988; Maeda et al., 1988) . Taken together, these studies indicate that each probe recognizes a unique receptor mRNA. For in situ hybridization histochemistry, all probes were labeled on the 3' end using terminal deoxynucleotidyl transferase (Bethesda Research Labs) and YIdeoxyadenosine 5'-[a-thioltriphosphate as previously described (Young et al., 1986 ). 
Results
Characterization of muscarinic receptors in sweat glands To determine the concentration (B,,,,) and dissociation constant (&) of the muscarinic cholinergic receptor in rat sweat glands, homogenates of gland-rich tissue were incubated with concentrations of [3H]NMS ranging from 0.025 to 1.25 nM. The muscarinic binding sites were saturated between 0.8 and 1.2 nM [3H]NMS. Scatchard analysis of these data revealed that the concentration of muscarinic receptors was 30 1 fmol/mg membrane protein and the Kd was 131 PM (Fig. 1) . Competition studies with well-characterized muscarinic antagonists and agonists demonstrated a typical muscarinic cholinergic pharmacology (Fig. 2a) (Fig. 2b) . In our assay system, 4-DAMP inhibited [3H]NMS binding with high affinity. Pirenzepine inhibited ['H]NMS binding with intermediate affinity in homogenates of gland-rich tissue. The putative M, heart-specific analog of pirenzepine, AF DX-116, bound to muscarinic binding sites in gland-rich tissue with low affinity.
Since the tissue used for the muscarinic binding assays was heterogeneous and contained fat cells and blood vessels as well as sweat glands, receptor autoradiography was performed to localize [3H]NMS binding sites in footpads. Grains representing specific binding were concentrated over the secretory coil and were absent from blood vessels and the surrounding connective tissue (Fig. 3) . The density of grains associated with the secretory duct appeared lower than that associated with the secretory coil; however, since relatively few sections contained secretory duct, this difference was not examined quantitatively. Ligand binding sites appeared to be uniformly distributed over the secretory coil. Basbaum et al. (1984) have reported that ligand binding sites in both tracheal serous and mucous glands are primarily associated with the basolateral surface. The autoradiographic method used in the present studies, however, did not possess sufficient resolution to reveal such a distribution pattern in rat sweat glands or to distinguish binding to secretory cells or myoepithelial cells within the coil or to possible presynaptic receptors in the gland innervation. Thus, sweat glands were the only structure with significant levels of muscarinic binding sites in the footpad, and these sites are expressed in the glands themselves.
In situ hybridization histochemistry performed on sections of adult rat footpad demonstrated the presence of mRNA encoding the m3 molecular subtype of the muscarinic receptor (Fig.  4a,b) . Sections of rat footpad were screened with oligonucleotide probes selective for each of the five molecular subtypes. Following hybridization, only the m3 mRNA was detectable. While message for the ml, as well as the m3, receptor subtype has been described in porcine parotid gland, we found no evidence for Figure 5 . Sweating response in an adult rat with a unilateral lesion of the sciatic nerve. The animal was given a subcutaneous injection of the pilocarpine (3 mg/kg), and secretion was assayed 20 min postinjection. a, The glands in the control footpad respond robustly to the pilocarpine challange. Each pore, which appears as a white spot, represents the activity of a single gland. !I, The glands in the denervated footpad did not respond to the muscarinic agonist. Magnification, 15 x .
the expression of ml mRNA in rat sweat gland (Figure 4c,d ) even though our ml probe exhibited the expected distribution on sections of rat brain (data not shown).
Efects of denervation on muscarinic receptor expression To investigate the possible effects of denervation on the expression of muscarinic choline& receptors, we determined the concentration and Kd of muscat-uric receptors in homogenates of gland-rich tissue isolated from acutely denervated adult animals. Sweat glands were denervated by sectioning the sciatic nerve 7 d prior to assay. Previous studies have demonstrated that following denervation rat and mouse sweat glands do not sweat in response to local or systemic treatment with cholinergic agonists (Hayashi and Nakagawa, 1963; , and we found that sensitivity to cholinergic agonists was absent 7 d following sciatic nerve lesion (Fig. 5) . Homogenates of control and denervated gland-rich tissue were incubated with concentrations of ['H]NMS ranging from 0.025 to 1.2 nM, and binding data were analyzed by the method of Scatchard. The concentration of muscarinic binding sites was 239 fmol/mg membrane protein, and the Kd was 2 19 PM (Fig. 6) . These values are not significantly different from those obtained for the concentration and Kd for muscarinic receptors in footpads on the contralateral unoperated side (27 1 fmol/mg protein and 18 1 PM, respectively; p > 0.05).
The distribution and molecular subtype of muscarinic binding sites in denervated sweat glands were similar to those of control glands (Fig. 7) . Quantitative analysis of receptor autoradiogra- phy indicated that the grain density over denervated glands was not significantly different than over control glands. In situ hybridization studies demonstrated that, as in control glands, only mRNA encoding the m3 receptor subtype was detectable in denervated glands. Furthermore, both expressed similar levels of this mRNA, the density of grains over denervated glands when compared to control glands was unchanged as well.
Discussion
In these studies we have characterized the properties of muscarinic receptors in adult rat sweat glands and examined the effects of denervation on muscarinic reCeptOr expression, a treatment that causes loss of functional responsiveness in the glands. The muscarinic cholinergic receptor expressed by the glands is the M, glandular receptor, and both the affinity and concentration of these sites are comparable to those described for other peripheral tissues. This pharmacologically defined receptor subtype corresponds to the m3 molecular subtype. Denervation of adult rat sweat glands did not significantly change either the concentration or the athnity of muscarinic receptors, nor did it detectably alter the molecular subtype expressed. Receptor autoradiography revealed that the distribution and concentration of specific grains were unchanged as well. Thus, cholinergic innervation does not regulate the functional responsiveness of rat sweat glands at the level of receptor expression.
The pharmacological properties of the muscarinic binding site in rat sweat glands as determined with the nonselective muscarinic antagonist ['H]NMS are consistent with those described in previous studies of other peripheral autonomic target tissues (Dehaye et al., 1984; Siegel and Fischbach, 1984; Waelbroeck et al., 1986 Waelbroeck et al., , 1987 . Analysis of saturation curves suggested that The density of specific grains was not significantly different for receptor autoradiography (93 + 7% of control) or in situ hybridization (103 * 9% of control). Receptor autoradiograms were exposed for 12 weeks, and in situ hybridization autoradiograms were exposed for 6 weeks. Magnification, 3 15 x .
[3H]NMS bound to a single site with high affinity. Competition studies with well-characterized muscarinic ligands produced the following order of potency: atropine > oxotremorine > pilocarpine > carbachol. This order of potency is consistent with previous studies of other peripheral muscarinic receptors (Hootman and Ernst, 198 1; Dehaye et al., 1984) . Using selective muscarinic antagonists, we determined that the muscarinic site exhibited high affinity for 4-DAMP, intermediate affinity for pirenzepine, and low affinity for AF DX-116. Based on our studies and the studies cited above, the muscarinic receptor expressed in rat sweat glands can be defined pharmacologically as an M, glandular muscarinic receptor.
It is not clear, however, that receptors defined pharmacologically in each tissue type as M, glandular all correspond to the same unique molecular subtype (see Hootman et al., 1985) . Using oligonucleotide probes specific for each of the five muscarinic receptor molecular subtypes, we have determined that mRNA encoding the m3 receptor subtype is present in adult rat sweat glands. Message for the other muscarinic receptor subtypes was not detected. Expression studies utilizing cell lines transfected with muscarinic receptor cDNAs have suggested that the muscarinic receptor encoded by the m3 gene displays a pharmacological profile attributed to the M, glandular pharmacological subtype (Peralta et al., 1987a; Akiba et al., 1988; Bonner et al., 1988) . Accordingly, one would predict that the receptor encoded by the m3 gene corresponds to the M, glandular receptor; whether the pharmacological properties determined in cell line expression studies necessarily correspond to those of the native receptors in vivo has not yet been examined in detail. Our results provide support for this identification since sweat glands express detectable levels of only the m3 message and the pharmacological properties of the sweat gland receptor are characteristic of the M, glandular subtype.
Choline& denervation produced little change in the distribution or pharmacological properties of muscarinic receptors expressed by rat sweat glands. Interestingly, 3-5 d after sciatic nerve lesion, the glands no longer respond to administration of cholinergic agonists despite the presence of a normal complement of muscarinic binding sites. A similar discrepancy between the presence of muscarinic binding sites and cholinergic sensitivity has been described in cultured chick myocytes (Siegel and Fischbach, 1984) . Furthermore, the affinity of the muscarinic site was unchanged following denervation, and the saturation curve was not fit significantly better by a two-site model; these observations suggest that a new class of receptors was not expressed following denervation. In other studies, denervation of other peripheral autonomic targets resulted in increases, decreases, or no change in the concentration of muscarinic receptors (Sachs et al., 1979; Talamo et al., 1979; Nilvebrant et al., 1986) . In rat parotid gland, the most similar to sweat glands of the tissues examined, muscarinic receptor concentration was reduced slightly following denervation; the gland, however, became supersensitive to muscarinic stimulation (Talamo et al., 1979; Ekstrom, 1980) . Thus, innervation may have similar effects onthe expression of muscarinic receptors in both parotid and sweat glands; however, innervation clearly regulates postreceptor coupling to secretion in a very different manner.
The signal transduction pathway regulating secretion in the rat sweat gland has not yet been fully elucidated. Thus far, sweat secretion in rats has been shown to be calcium dependent and consist of a high potassium and chloride effluent (Sat0 and Sato, 1978) . Studies performed on other exocrine gland cells, principally lacrimal cells, suggest that secretion is stimulated via the PI pathway. In lacrimal cells the generation of inositol triphosphate promotes the release of intracellular CaZ+, which activates potassium and chloride ion channels (Trautman and Marty, 1984; Evans and Marty, 1986 ; reviewed by Marty, 1987) . In addition, the coupling of muscarinic receptors to secretion has been extensively investigated in the parotid gland, where it is also thought to be regulated through the PI pathway (Haddas et al., 1979; Aub et al., 1982) . It seems likely that a similar mechanism occurs in rat sweat glands, where the m3 molecular subtype, which has been shown previously to be preferentially coupled to PI turnover, is expressed (Fukuda et al., 1988; Peralta et al., 1988) .
Clearly, there are several points in the signal transduction/ secretory pathway at which cholinergic innervation could control responsiveness. One possibility is that innervation regulates the expression of the appropriate muscarinic receptor subtype. This is analogous to the reexpression of the r-subunit of the skeletal muscle nicotinic ACh receptor that occurs following the denervation (Moss et al., 1987; Witzemann et al., 1987; Gu and Hall, 1988) . However, our finding that the molecular subtype of muscarinic receptor and the levels of mRNA remain unchanged following denervation makes this unlikely. An alternative explanation is that the appropriate receptor is present but exists in a nonfunctional state. This phenomenon has been described for the neuronal nicotinic ACh receptor in chick ciliary ganglion; in these cells, agents that increase intracellular levels of CAMP induce increases in the number of functional receptors, possibly by phosphorylating the receptor or an associated regulatory protein (Margiotta et al., 1987 ; reviewed by Berg et al., 1989) . While a precedent for this type of regulation does not exist for G-protein-coupled receptors, phosphorylation has been suggested to play a role in agonist-mediated downregulation of p-adrenergic receptors (Benovic et al., 1986) .
Another explanation for functional nonresponsiveness is that a functional receptor is present but uncoupled from the secretory pathway. This could occur either through the absence or downregulation of the appropriate G-protein(s) or at a point distal to the G-protein. Both of these mechanisms have been observed in embryonic and early postnatal chick hearts. In this tissue the onset of muscarinic cholinergic-mediated inhibition of adenyl cyclase is correlated with the appearance of the 39 kDa G-protein a-subunit (Halvorson and Nathanson, 1984; Liang et al., 1986) . In the same experimental system, however, a step distal to the G-protein can also be downregulated Nathanson, 1984, 1986) . Our results suggest that the latter type of regulation also occurs in rat sweat glands, where G-protein coupling is unaffected by denervation (Grant and Landis, 199 1) . Identification of the step or steps compromised by denervation will provide valuable insight into the mechanisms by which innervation can regulate responsiveness in autonomic target tissues.
